COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
MitoChem, an MUSC spinoff in Charleston, develops mitochondrial-protective small-molecule eye-drop drug candidates for retinal diseases (macular degeneration, retinitis pigmentosa), advancing lead from 50,000-compound screen through preclinical animal studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor